首页|期刊导航|中国神经再生研究(英文版)|The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke
中国神经再生研究(英文版)2024,Vol.19Issue(9):1998-2003,6.DOI:10.4103/1673-5374.390959
The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke
The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke
摘要
关键词
ischemic stroke/mesenchymal stem cells/metabolomics/multilevel omics/neural stem/progenitor cells/neuroinflammation/pathophysiology/proteomics/stem cell therapy/transcriptomesKey words
ischemic stroke/mesenchymal stem cells/metabolomics/multilevel omics/neural stem/progenitor cells/neuroinflammation/pathophysiology/proteomics/stem cell therapy/transcriptomes引用本文复制引用
Yiqing Wang,Chuheng Chang,Renzhi Wang,Xiaoguang Li,Xinjie Bao..The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke[J].中国神经再生研究(英文版),2024,19(9):1998-2003,6.基金项目
This work was supported by the National Key Research and Development Program of China,No.2018YFA0108602 ()
the CAMS Initiative for Innovative Medicine,No.2021-1-I2M-019 ()
the National High Level Hospital Clinical Research Funding,No.2022-PUMCH-C-042(all to XB). (all to XB)